BIZZI, EMANUELE
 Distribuzione geografica
Continente #
AS - Asia 765
EU - Europa 736
NA - Nord America 449
SA - Sud America 246
AF - Africa 21
Totale 2.217
Nazione #
RU - Federazione Russa 572
US - Stati Uniti d'America 410
SG - Singapore 314
CN - Cina 198
BR - Brasile 191
VN - Vietnam 122
HK - Hong Kong 69
FR - Francia 66
IT - Italia 32
MX - Messico 22
AR - Argentina 19
GB - Regno Unito 18
EC - Ecuador 16
DE - Germania 14
IN - India 13
ZA - Sudafrica 12
BD - Bangladesh 10
CO - Colombia 8
CA - Canada 7
ID - Indonesia 7
NL - Olanda 7
PL - Polonia 6
PY - Paraguay 6
GT - Guatemala 5
TR - Turchia 5
IQ - Iraq 4
PK - Pakistan 4
DZ - Algeria 3
ES - Italia 3
JP - Giappone 3
MA - Marocco 3
SE - Svezia 3
AE - Emirati Arabi Uniti 2
CL - Cile 2
FI - Finlandia 2
KH - Cambogia 2
KZ - Kazakistan 2
NI - Nicaragua 2
RO - Romania 2
TN - Tunisia 2
UA - Ucraina 2
VE - Venezuela 2
AT - Austria 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BH - Bahrain 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
IE - Irlanda 1
IL - Israele 1
JO - Giordania 1
LB - Libano 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
MY - Malesia 1
PH - Filippine 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SV - El Salvador 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 2.217
Città #
Singapore 172
Moscow 120
Ashburn 83
San Jose 72
Dallas 70
Hong Kong 69
Beijing 55
Lauterbourg 44
Ho Chi Minh City 38
Los Angeles 23
Hanoi 20
New York 19
São Paulo 19
Mexico City 13
Santa Clara 12
Frankfurt am Main 11
Da Nang 10
Haiphong 9
Hefei 9
Guangzhou 8
Guayaquil 8
Johannesburg 8
Orem 8
Atlanta 7
Chicago 6
Curitiba 6
Denver 6
Houston 6
Hải Dương 6
Poplar 6
Milan 5
Phoenix 5
Porto Alegre 5
Rome 5
São Bernardo do Campo 5
Brooklyn 4
Chennai 4
Guatemala City 4
Quito 4
Shenzhen 4
Warsaw 4
Asunción 3
Belo Horizonte 3
Biên Hòa 3
Changsha 3
Chongqing 3
Manaus 3
Mumbai 3
Phủ Lý 3
Providence 3
Querétaro 3
Rio de Janeiro 3
Stockholm 3
Thái Bình 3
Tianjin 3
Tokyo 3
Almaty 2
Alto Paraíso de Goiás 2
Bologna 2
Boston 2
Buenos Aires 2
Busto Arsizio 2
Bắc Giang 2
Campinas 2
Can Tho 2
Cape Town 2
Council Bluffs 2
Córdoba 2
Florianópolis 2
Gramado 2
Huế 2
Iași 2
Istanbul 2
Itanhaém 2
Ivanovo 2
Jakarta 2
Juiz de Fora 2
Limeira 2
London 2
Londrina 2
Lấp Vò 2
Machala 2
Manado 2
Managua 2
Manchester 2
Medellín 2
Montreal 2
Monza 2
Nha Trang 2
Nuremberg 2
Paris 2
Phnom Penh 2
Piracicaba 2
Recife 2
Ribeirão Preto 2
Roubaix 2
Salvador 2
Shanghai 2
São José 2
Toronto 2
Totale 1.125
Nome #
Exploring IL-1 inhibition in chronic refractory idiopathic myocarditis: emerging insights and perspectives 110
Autoimmune and Autoinflammatory Pericarditis: Definitions and New Treatments 75
An update on the up and coming therapies to treat osteoarthritis, a multifaceted disease 73
Indirect comparison between subcutaneous biologic agents in ankylosing spondylitis 71
Acute pericarditis with pleuropulmonary involvement, fever and elevated C-reactive protein: A systemic autoinflammatory disease? A cohort study 70
Immunomodulating Therapies in Acute Myocarditis and Recurrent/Acute Pericarditis 65
HyalOne® in the treatment of symptomatic hip OA - data from the ANTIAGE register: seven years of observation 64
High levels of NK cells in the peripheral blood of patients affected with anti-phospholipid syndrome and recurrent spontaneous abortion: a potential new hypothesis 63
A double blind randomized active-controlled clinical trial on the intra-articular use of Md-Knee versus sodium hyaluronate in patients with knee osteoarthritis ("Joint") 63
Differences among Branded Hyaluronic Acids in Italy, Part 1: Data from In Vitro and Animal Studies and Instructions for Use 62
Disinfectant caps in vitro effectiveness 62
Pericardial Diseases in Pregnancy 62
Comparative, double-blind, controlled study of intra-articular hyaluronic acid (Hyalubrix) injections versus local anesthetic in osteoarthritis of the hip 61
Duration of symptom relief after intra-articular injection of hyaluronic acid combined with sorbitol (anti-ox-vs) in symptomatic hip osteoarthritis 61
Differences Regarding Branded HA in Italy, Part 2: Data from Clinical Studies on Knee, Hip, Shoulder, Ankle, Temporomandibular Joint, Vertebral Facets, and Carpometacarpal Joint 60
COVID-19 and gender differences: Lights and shadows 54
COVID-19 welbeing study: A protocol examining perceived coercion and psychological well-being during the COVID-19 pandemic by means of an online survey, asynchronous virtual focus groups and individual interviews 53
Can Cyclosporine-A associated to methotrexate maintain remission induced by anti-TNF agents in rheumatoid arthritis patients? (Cynar pilot study) 52
A new chance to maintain remission induced by anti-TNF agents in rheumatoid arthritis patients: CYnAR study II of a 12-month follow-up 50
An open randomized active-controlled clinical trial with low-dose SKA cytokines versus DMARDs evaluating low disease activity maintenance in patients with rheumatoid arthritis 50
Efficacy of biological agents administered as monotherapy in rheumatoid arthritis: a Bayesian mixed-treatment comparison analysis 49
Inflammatory puzzle: Unveiling the role of D-Dimer in acute pericarditis and thromboinflammation 45
Relapsing pericarditis: Peripheral blood neutrophilia, lymphopenia and high neutrophil-to-lymphocyte ratio herald acute attacks, high-grade inflammation, multiserosal involvement, and predict multiple recurrences 41
The Challenge of Treating Early-Stage Rheumatoid Arthritis: The Contribution of Mixed Treatment Comparison to Choosing Appropriate Biologic Agents 41
The administration of methotrexate in patients with Still's disease, "real-life" findings from AIDA Network Still Disease Registry 40
Unfolding dermatologic spectrum of Behçet's disease in Italy: real-life data from the International AIDA Network Behçet's disease Registry 39
Management of acute and recurrent pericarditis in pregnancy 39
Post-cardiac injury syndrome and pericardial effusion recurrence after pericardial effusion drainage in chronic idiopathic pericardial effusion 37
The safety of anti-TNF agents in the elderly 37
Intra-articular administration of hylan G-F 20 in patients with symptomatic hip osteoarthritis: tolerability and effectiveness in a large cohort study in clinical practice 37
Viscosupplementation in the management of ankle osteoarthritis: a review 36
Multiple chemical sensitivity syndrome in Sjögren's syndrome patients: casual association or related diseases? 33
Safety of intra-articular hip injection of hyaluronic acid products by ultrasound guidance: an open study from ANTIAGE register 33
Total hip replacement rate in a cohort of patients affected by symptomatic hip osteoarthritis following intra-articular sodium hyaluronate (MW 1,500-2,000 kDa) ORTOBRIX study 32
Intra-articular injection of hyaluronic acid (MW 1,500-2,000 kDa; HyalOne) in symptomatic osteoarthritis of the hip: a prospective cohort study 32
Is it the time to rethink clinical decision-making strategies? From a single clinical outcome evaluation to a Clinical Multi-criteria Decision Assessment (CMDA) 31
Indirect comparison of the effects of anti-TNF biological agents in patients with ankylosing spondylitis by means of a mixed treatment comparison performed on efficacy data from published randomised, controlled trials 31
Recent advances in pericarditis 31
Vasculitis and COVID-19: What do we have to know? 31
The discrepancy between recommendations and clinical practice for viscosupplementation in osteoarthritis: mind the gap! 30
Mixed-treatment comparison of anabolic (teriparatide and PTH 1-84) therapies in women with severe osteoporosis 29
Use of viscosupplementation for the recovery of active football players complaining of knee pain 29
Socioeconomic burden of total joint arthroplasty for symptomatic hip and knee osteoarthritis in the Italian population: a 5-year analysis based on hospitalization records 26
Prevalence study of iliopsoas bursitis in a cohort of 860 patients affected by symptomatic hip osteoarthritis 26
Local approaches to sacro-iliac joint pathologies: several unanswered questions 25
The impact of treatment with hylan G-F 20 on progression to total hip arthroplasty in patients with symptomatic hip OA: a retrospective study 25
Indirect comparison of etanercept, infliximab, and adalumimab for psoriatic arthritis: mixed treatment comparison using placebo as common comparator 25
Interstitial lung disease in rheumatoid arthritis in the era of biologics 25
Radiological outcomes in randomized controlled trials on biologic therapies for rheumatoid arthritis: a narrative review 25
Indirect comparison of etanercept, infliximab, and adalimumab for psoriatic arthritis: mixed treatment comparison using placebo as common comparator 23
Mixed panniculitis responding to cyclosporin-A with a 12-month follow-up: a case report 22
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospective Italian P-RHEUM.it study 1
Totale 2.287
Categoria #
all - tutte 5.960
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.960


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025117 0 0 0 0 0 0 0 0 0 0 0 117
2025/20262.170 91 243 195 426 151 64 164 190 529 104 13 0
Totale 2.287